PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
INFN vs. INFI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between INFN and INFI is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

INFN vs. INFI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Infinera Corporation (INFN) and Infinity Pharmaceuticals, Inc. (INFI). The values are adjusted to include any dividend payments, if applicable.

-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%-70.00%-65.00%SeptemberOctoberNovemberDecember2025February
-66.25%
-99.97%
INFN
INFI

Key characteristics

Fundamentals

Market Cap

INFN:

$1.57B

INFI:

$726.09K

EPS

INFN:

-$0.47

INFI:

-$0.44

PEG Ratio

INFN:

-0.76

INFI:

-0.05

Returns By Period


INFN

YTD

1.22%

1M

0.61%

6M

10.28%

1Y

27.64%

5Y*

-3.49%

10Y*

-9.10%

INFI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

INFN vs. INFI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INFN
The Risk-Adjusted Performance Rank of INFN is 7070
Overall Rank
The Sharpe Ratio Rank of INFN is 7272
Sharpe Ratio Rank
The Sortino Ratio Rank of INFN is 6969
Sortino Ratio Rank
The Omega Ratio Rank of INFN is 7373
Omega Ratio Rank
The Calmar Ratio Rank of INFN is 6464
Calmar Ratio Rank
The Martin Ratio Rank of INFN is 7373
Martin Ratio Rank

INFI
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

INFN vs. INFI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Infinera Corporation (INFN) and Infinity Pharmaceuticals, Inc. (INFI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for INFN, currently valued at 0.80, compared to the broader market-2.000.002.004.000.80
The chart of Sortino ratio for INFN, currently valued at 1.47, compared to the broader market-6.00-4.00-2.000.002.004.006.001.47
The chart of Omega ratio for INFN, currently valued at 1.22, compared to the broader market0.501.001.502.001.22
The chart of Calmar ratio for INFN, currently valued at 0.44, compared to the broader market0.002.004.006.000.44
The chart of Martin ratio for INFN, currently valued at 3.33, compared to the broader market-10.000.0010.0020.0030.003.33
INFN
INFI


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.80
1.00
INFN
INFI

Dividends

INFN vs. INFI - Dividend Comparison

Neither INFN nor INFI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

INFN vs. INFI - Drawdown Comparison


-100.00%-95.00%-90.00%-85.00%-80.00%-75.00%SeptemberOctoberNovemberDecember2025February
-75.42%
-99.99%
INFN
INFI

Volatility

INFN vs. INFI - Volatility Comparison

Infinera Corporation (INFN) has a higher volatility of 1.68% compared to Infinity Pharmaceuticals, Inc. (INFI) at 0.00%. This indicates that INFN's price experiences larger fluctuations and is considered to be riskier than INFI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%2.00%4.00%6.00%8.00%SeptemberOctoberNovemberDecember2025February
1.68%
0
INFN
INFI

Financials

INFN vs. INFI - Financials Comparison

This section allows you to compare key financial metrics between Infinera Corporation and Infinity Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab